GR3018729T3 - 1,4-Dihydropyridines. - Google Patents

1,4-Dihydropyridines.

Info

Publication number
GR3018729T3
GR3018729T3 GR960400116T GR960400116T GR3018729T3 GR 3018729 T3 GR3018729 T3 GR 3018729T3 GR 960400116 T GR960400116 T GR 960400116T GR 960400116 T GR960400116 T GR 960400116T GR 3018729 T3 GR3018729 T3 GR 3018729T3
Authority
GR
Greece
Prior art keywords
optionally substituted
sub
formula
represent
group
Prior art date
Application number
GR960400116T
Other languages
English (en)
Inventor
John Leheup Archibald
Terence James Ward
Albert Opalko
Original Assignee
Wyeth John & Brother Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wyeth John & Brother Ltd filed Critical Wyeth John & Brother Ltd
Publication of GR3018729T3 publication Critical patent/GR3018729T3/el

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D211/00Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/80Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D211/84Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen directly attached to ring carbon atoms
    • C07D211/90Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D231/00Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/12Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/08Vasodilators for multiple indications
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/12Antihypertensives
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D233/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/56Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D249/00Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/081,2,4-Triazoles; Hydrogenated 1,2,4-triazoles

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Manufacture Of Tobacco Products (AREA)
  • Saccharide Compounds (AREA)
GR960400116T 1986-02-01 1996-01-18 1,4-Dihydropyridines. GR3018729T3 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB868602518A GB8602518D0 (en) 1986-02-01 1986-02-01 1 4-dihydropyridines

Publications (1)

Publication Number Publication Date
GR3018729T3 true GR3018729T3 (en) 1996-04-30

Family

ID=10592383

Family Applications (1)

Application Number Title Priority Date Filing Date
GR960400116T GR3018729T3 (en) 1986-02-01 1996-01-18 1,4-Dihydropyridines.

Country Status (12)

Country Link
US (1) US5064842A (el)
EP (1) EP0233015B1 (el)
JP (1) JPH0723370B2 (el)
KR (1) KR950003922B1 (el)
AT (1) ATE129242T1 (el)
CA (1) CA1329600C (el)
DE (1) DE3751562T2 (el)
ES (1) ES2078215T3 (el)
GB (2) GB8602518D0 (el)
GR (1) GR3018729T3 (el)
HU (1) HU199139B (el)
PT (1) PT84206B (el)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2036128B1 (es) * 1991-07-10 1993-12-16 Menarini Lab Procedimiento para la preparacion de 4-(imidazo)1,5-a)piridin-8l)-1,4-dihidropiridinas.
US5288866A (en) * 1991-12-20 1994-02-22 American Cyanamid Company 5,6-disubstituted-3-pyridylmethyl ammonium halide compounds useful for the preparation of 5- (substituted methyl)-2,3-pyridinedicarboxylic acids

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2738153A1 (de) * 1977-08-24 1979-03-08 Bayer Ag 2-pyridyl-1,4-dihydropyridine, verfahren zu ihrer herstellung sowie ihre verwendung als arzneimittel
CA1117117A (en) * 1978-10-10 1982-01-26 Fujisawa Pharmaceutical Co., Ltd. 2-methyl-dihydropyridine compound, processes for preparation thereof and pharmaceutical composition comprising the same
DE3269219D1 (en) * 1981-11-17 1986-03-27 Fisons Plc Dihydropyridines, methods for their production and their formulation and use as pharmaceuticals
DE3207982A1 (de) * 1982-03-05 1983-09-08 Bayer Ag, 5090 Leverkusen Neue 1,4-dihydropyridine, verfahren zu ihrer herstellung und ihrer verwendung in arzneimitteln
DE3363743D1 (en) * 1982-07-22 1986-07-03 Pfizer Ltd Dihydropyridine anti-ischaemic and antihypertensive agents
US4607041A (en) * 1983-04-27 1986-08-19 Fisons Plc Antihypertensive 2-phenyl Hantzsch dihydropyridines
GR851819B (el) * 1984-08-17 1985-11-26 Wyeth John & Brother Ltd
EP0174131A3 (en) * 1984-09-01 1989-06-07 FISONS plc Dihydropyridines, processes and intermediates for their production, and pharmaceutical formulations containing them
EP0225175A3 (en) * 1985-11-28 1988-12-28 FISONS plc Dihydropyridine derivatives, processes for their preparation and pharmaceutical compositions thereof

Also Published As

Publication number Publication date
KR870007889A (ko) 1987-09-22
PT84206A (en) 1987-02-01
US5064842A (en) 1991-11-12
GB2185982A (en) 1987-08-05
DE3751562T2 (de) 1996-04-11
CA1329600C (en) 1994-05-17
EP0233015A2 (en) 1987-08-19
DE3751562D1 (de) 1995-11-23
GB2185982B (en) 1990-05-16
EP0233015B1 (en) 1995-10-18
HUT45988A (en) 1988-09-28
ATE129242T1 (de) 1995-11-15
PT84206B (pt) 1989-11-30
ES2078215T3 (es) 1995-12-16
GB8602518D0 (en) 1986-03-05
KR950003922B1 (ko) 1995-04-20
JPS62201868A (ja) 1987-09-05
JPH0723370B2 (ja) 1995-03-15
HU199139B (en) 1990-01-29
EP0233015A3 (en) 1990-11-07
GB8702016D0 (en) 1987-03-04

Similar Documents

Publication Publication Date Title
PH25218A (en) Reverse hydroxamates
ZA803251B (en) Pyroglutamic acid derivatives and analogs
ES8604564A1 (es) Procedimiento de obtencion de derivados de 4-aril-1,4-dihi- dropiridinas
ZA854689B (en) 5-amino-4-heterocyclyl-1-phenylpyrazoles
MY100115A (en) Nitrogen containing heterocyclic compounds, and their production and use.
ES455151A1 (es) Procedimiento para la obtencion de n-arildiazaciclos oxige- nados.
DE3675316D1 (en) Dihydropyridine.
DK0382660T3 (da) Dioxaphosphorinanforbindelser og dermed stabiliserede polyolefinmaterialer
TW197421B (el)
GB2185982B (en) 1,4-dihydropyridines
ES551421A0 (es) Un procedimiento para preparar imidazol-5-carboximidatos
PL255529A1 (en) Method of obtaining novel n-alyl/en/o-n/",o-disubstituted thiophosphoryl/-n',n'-disubstituted glicinamides
EP0253502A3 (en) Tertiary amine compounds
EG19000A (en) Glycine compounds
DE3572483D1 (en) Carboxamide derivatives, their preparation and their use as fungicides
ATE31404T1 (de) Verfahren zur herstellung von cycklopropanabkoemmlingen.
ES2091287T3 (es) Compuestos polimericos.